Lista de obras - Nicolai J Wewer Albrechtsen

A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats

artículo científico publicado en 2016

A knowledge graph to interpret clinical proteomics data

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

artículo científico publicado en 2017

Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice

An Analysis of Cosecretion and Coexpression of Gut Hormones From Male Rat Proximal and Distal Small Intestine

article

Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.

artículo científico publicado en 2018

Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents

artículo científico publicado en 2019

Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy

artículo científico publicado en 2020

Can online based learning activities improve learning outcomes in classroom teaching? ⬇️

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

artículo científico publicado en 2017

Defining NASH from a Multi-Omics Systems Biology Perspective

artículo científico publicado en 2021

Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis

artículo científico publicado en 2017

Do glucagonomas always produce glucagon?

artículo científico publicado en 2016

Dynamic human liver proteome atlas reveals functional insights into disease pathways

artículo científico publicado en 2022

Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes.

artículo científico publicado en 2016

Effects of Exercise Training and IL-6 Receptor Blockade on Gastric Emptying and GLP-1 Secretion in Obese Humans: Secondary Analyses From a Double Blind Randomized Clinical Trial ⬇️

scientific article published on 04 October 2019

Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial

artículo científico publicado en 2020

Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597

artículo científico publicado en 2016

Evidence of Extrapancreatic Glucagon Secretion in Man

article

Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

artículo científico publicado en 2018

GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines

artículo científico publicado en 2014

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass.

artículo científico publicado en 2015

Glucagon Receptor Signaling and Glucagon Resistance

scientific article published on 05 July 2019

Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.

artículo científico publicado en 2017

Glucagon receptor signaling in metabolic diseases

artículo científico publicado en 2018

Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes

artículo científico publicado en 2016

Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors

artículo científico publicado en 2017

Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influx

artículo científico publicado en 2015

Health care professionals from developing countries report educational benefits after an online diabetes course

artículo científico publicado en 2017

Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides

artículo científico publicado en 2015

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

artículo científico publicado en 2014

Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes

artículo científico publicado en 2017

Identification of ADAM12 as a Novel Basigin Sheddase

artículo científico publicado en 2019

Important species differences regarding lymph contribution to gut hormone responses

artículo científico publicado en 2015

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.

artículo científico publicado en 2015

Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine

artículo científico publicado en 2018

Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control

artículo científico publicado en 2018

Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.

artículo científico publicado en 2014

Neuromedin U Does Not Act as a Decretin in Rats

artículo científico publicado en 2018

No effects of a six-week intervention with glucagon-like peptide-1 receptor analogue on pancreatic volume and edema in obese men without diabetes

artículo científico publicado en 2020

No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post-hoc analysis from the randomized controlled PRE-D trial

artículo científico publicado en 2020

Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

artículo científico publicado en 2020

On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat.

artículo científico publicado en 2017

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

artículo científico publicado en 2016

Oxyntomodulin: Actions and role in diabetes

artículo científico publicado en 2018

Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation

artículo científico publicado en 2016

Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice

artículo científico publicado en 2019

Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia

artículo científico publicado en 2017

Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.

artículo científico publicado en 2016

Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery

artículo científico publicado en 2018

Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice

artículo científico publicado en 2020

Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease

scientific article published on 01 March 2019

Predictors of weight loss after bariatric surgery-a cross-disciplinary approach combining physiological, social, and psychological measures

scientific article published on 23 April 2020

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

artículo científico publicado en 2020

Proteomics reveals the effects of sustained weight loss on the human plasma proteome

artículo científico publicado en 2016

Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RES

artículo científico publicado en 2020

Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery

artículo científico publicado en 2020

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass

artículo científico publicado en 2017

Sacubitril/valsartan augments postprandial plasma concentrations of active GLP-1 when combined with sitagliptin in men

scientific article published on 10 May 2019

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma

scientific article published on 01 April 2020

Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine

artículo científico publicado en 2020

Secretion of parathyroid hormone may be coupled to insulin secretion in humans

artículo científico publicado en 2020

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

artículo científico publicado en 2014

Stability of glucagon-like peptide 1 and glucagon in human plasma

artículo científico publicado en 2015

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

artículo científico publicado en 2018

Targeting the intestinal L-cell for obesity and type 2 diabetes treatment

artículo científico publicado en 2013

Testicular germ cell tumors and related research from a historical point of view.

artículo científico

The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial

artículo científico publicado en 2020

The Gut: A Key to the Pathogenesis of Type 2 Diabetes?

artículo científico publicado en 2017

The biology of glucagon and the consequences of hyperglucagonemia.

artículo científico publicado en 2016

The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers

artículo científico publicado en 2017

The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs

artículo científico publicado en 2016

The liver-alpha cell axis and type 2 diabetes

scientific article published on 01 October 2019

The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels

artículo científico publicado en 2020

Why is it so difficult to measure glucagon-like peptide-1 in a mouse?

artículo científico publicado en 2017

Lista de obras de Nicolai J Wewer Albrechtsen

A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats

A knowledge graph to interpret clinical proteomics data

A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice

An Analysis of Cosecretion and Coexpression of Gut Hormones From Male Rat Proximal and Distal Small Intestine

Bile acids are important direct and indirect regulators of the secretion of appetite- and metabolism-regulating hormones from the gut and pancreas.

Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents

Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy

Can online based learning activities improve learning outcomes in classroom teaching? ⬇️

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

Defining NASH from a Multi-Omics Systems Biology Perspective

Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis

Do glucagonomas always produce glucagon?

Dynamic human liver proteome atlas reveals functional insights into disease pathways

Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes.

Effects of Exercise Training and IL-6 Receptor Blockade on Gastric Emptying and GLP-1 Secretion in Obese Humans: Secondary Analyses From a Double Blind Randomized Clinical Trial ⬇️

Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial

Erratum. Evidence of Extrapancreatic Glucagon Secretion in Man. Diabetes 2016;65:585-597

Evidence of Extrapancreatic Glucagon Secretion in Man

Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass.

Glucagon Receptor Signaling and Glucagon Resistance

Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver-α-Cell Axis.

Glucagon receptor signaling in metabolic diseases

Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes

Glucagon-like peptide-1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP-1 receptors

Glucose stimulates neurotensin secretion from the rat small intestine by mechanisms involving SGLT1 and GLUT2, leading to cell depolarization and calcium influx

Health care professionals from developing countries report educational benefits after an online diabetes course

Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides

Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes

Identification of ADAM12 as a Novel Basigin Sheddase

Important species differences regarding lymph contribution to gut hormone responses

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion.

Inhibiting RHOA Signaling in Mice Increases Glucose Tolerance and Numbers of Enteroendocrine and Other Secretory Cells in the Intestine

Interleukin-6 Delays Gastric Emptying in Humans with Direct Effects on Glycemic Control

Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.

Neuromedin U Does Not Act as a Decretin in Rats

No effects of a six-week intervention with glucagon-like peptide-1 receptor analogue on pancreatic volume and edema in obese men without diabetes

No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post-hoc analysis from the randomized controlled PRE-D trial

Nonalcoholic Fatty Liver Disease Impairs the Liver-Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

On the relationship between glucose absorption and glucose-stimulated secretion of GLP-1, neurotensin, and PYY from different intestinal segments in the rat.

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

Oxyntomodulin: Actions and role in diabetes

Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation

Paracrine crosstalk between intestinal L- and D-cells controls secretion of glucagon-like peptide-1 in mice

Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia

Peptide production and secretion in GLUTag, NCI-H716, and STC-1 cells: a comparison to native L-cells.

Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery

Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice

Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease

Predictors of weight loss after bariatric surgery-a cross-disciplinary approach combining physiological, social, and psychological measures

Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study

Proteomics reveals the effects of sustained weight loss on the human plasma proteome

Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RES

Responses of gut and pancreatic hormones, bile acids, and fibroblast growth factor-21 differ to glucose, protein, and fat ingestion after gastric bypass surgery

Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass

Sacubitril/valsartan augments postprandial plasma concentrations of active GLP-1 when combined with sitagliptin in men

Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma

Secretin release after Roux-en-Y gastric bypass reveals a population of glucose-sensitive S cells in distal small intestine

Secretion of parathyroid hormone may be coupled to insulin secretion in humans

Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

Stability of glucagon-like peptide 1 and glucagon in human plasma

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

Targeting the intestinal L-cell for obesity and type 2 diabetes treatment

Testicular germ cell tumors and related research from a historical point of view.

The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial

The Gut: A Key to the Pathogenesis of Type 2 Diabetes?

The biology of glucagon and the consequences of hyperglucagonemia.

The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers

The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs

The liver-alpha cell axis and type 2 diabetes

The liver-alpha cell axis associates with liver fat and insulin resistance: a validation study in women with non-steatotic liver fat levels

Why is it so difficult to measure glucagon-like peptide-1 in a mouse?